Science Sparks @ ACTREC
08 December 2025Publications
- 1. Chavan P, Ojha S, Bhat V, Poojary M, Sharma N, Kannan S, Pillai B, Pal S, Sathyan V, Gupta S (2025). Prevalence of select micronutrient deficiencies in Indian voluntary blood donors. Asian Journal of Transfusion Science. 19(2):261-266.
- 2. Yadav SK, Garg G, Baderiya D, Bharath S, Sharma DB, Sharma D, Vidya R, Parmeshwar R, Yip CH, Suhani S, Deshpande AD, Mishra A, Srivastava A, Jha C, Kumar C, Hoysal DR, Calderon G, Agarwal G, Johri G, Jacob PM, Ramakant P, Chougle Q, Bichoo RA, Paulinelli R, Agrawal S, Sherwell-Cabello S, Das S, Chatterjee S, Cai S, Vishvak Chanthar KMM (2025). BRIDGEing the Gap: Impact of a Short Virtual Course on Delivering Global-Standard Breast Cancer Care in Low-Resource Settings. World Journal of Surgery.
- 3. Shenoy V, Kannan S, Noronha V, Prabhash K, Ostwal V, Bhargava P, Pillai A, Shamseeya K, Shetake A, Dhekale R, Chitre A, Gota V, Mahajan S, Daptardar A, Sonkusare L, Deodhar J, Ansari N, Vagal M, Mahajan P, Nookala M, Banavali SD, Ramaswamy A (2026). Development of a new model for prediction of relevant treatment related adverse events in older individuals with gastrointestinal cancers. Journal of Geriatric Oncology. 17(2):102817.
Book Chapter
Video of the Week
Improving Tools for Targeting AKT in Cancer
Upcoming Events
December 16-17, 2025
At ACTREC, Tata Memorial Centre, Kharghar, Navi Mumbai
December 20-21, 2025
At Seminar Room, 7th Floor, RRU, ACTREC,Kharghar
January 15-16, 2026
At ACTREC, Tata Memorial Centre, Kharghar
Do You Know?
In 2013, FDA approved trusted source ado-trastuzumab emtansine (T-DM1) to treat HER2-positive breast cancer.
Cancer News
News-Medical, 04/12/2025
The findings, outline a promising strategy that combines a PARP inhibitor, a targeted drug used to treat certain types of ovarian cancer, with a novel therapy, SM08502, to attack cancer from two directions...
EurekAlert, 03/12/2025
The study zeroed in on a type of helicase protein, a class of molecular motors that unwind genetic tangles called senataxin (SETX). SETX mutations are known for their role in rare neurological disorders, including ataxia and a form of amyotrophic lateral sclerosis (ALS)...
Sciencedaily, 01/12/2025
Researchers have found a small but powerful switch inside breast cancer cells that helps them survive stressful conditions. When this switch flips, the cells activate protective programs that make them tougher and faster-growing. The finding reveals how tumors use stress to their benefit. It may open up new...
© 2025 Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)